CompletedNot Applicable

Heart Health 4 New Moms: A Randomized Trial in the First Year After Preeclampsia

United States148 participantsStarted 2019-01-26

Plain-language summary

Preeclampsia causes devastating maternal and neonatal morbidity and mortality with a high recurrence risk and a rapid, occult progression to cardiovascular disease after delivery. There is a critical need for effective interventions to reduce these risks. This is a pilot randomized controlled trial of a novel postpartum lifestyle intervention compared to women who take home blood pressure measurements and women with usual care who are overweight and obese in the first year after preeclampsia. The investigators hypothesize that the intervention will lead to improved weight loss and blood pressure in the first year postpartum, which has broad implications for future pregnancy and long-term cardiovascular health.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * pre-pregnancy body mass index ≥25 kg/m2 * diagnosed with preeclampsia or gestational hypertension * access to internet Exclusion Criteria: * multiple gestation * medical co-morbidities: chronic kidney disease, active liver disease (acute hepatitis, chronic active hepatitis), active cardiac disease, pre-pregnancy diabetes mellitus, chronic hypertension diagnosed prior to pregnancy * pregnancy prior to randomization

What they're measuring

Weight loss

Timeframe: 4-8 weeks postpartum to 8-12 months postpartum

Trial details

NCT IDNCT03749746

SponsorUniversity of Pittsburgh

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12-01

View on ClinicalTrials.gov More Preeclampsia trials